Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | CCKBR | P32239 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.30 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919562 | 0.96 | RIPK1 (0.31) | ALDH1A1NPSR1 | |
| SCHEMBL25507090 | 0.87 | GABRA1 (0.33) | ALDH1A1NPSR1GABRA1GABRG2GABRB3 | |
| SCHEMBL23919874 | 0.87 | GABRA1 (0.33) | ALDH1A1NPSR1GABRA1GABRG2GABRB3 | |
| SCHEMBL23920060 | 0.87 | MAPK1 (0.33) | ALDH1A1KDM4ECHRNB4CHRNA3SETD7 | |
| SCHEMBL23919922 | 0.85 | P2RX4 (0.33) | ALDH1A1NPSR1KDM4E | |
| SCHEMBL25507153 | 0.84 | — | — | |
| SCHEMBL23919878 | 0.83 | GABRA1 (0.33) | ALDH1A1NPSR1GABRA1GABRG2GABRB3 | |
| SCHEMBL23919891 | 0.83 | GABRA1 (0.33) | ALDH1A1NPSR1GABRA1GABRG2GABRB3 | |
| SCHEMBL25507141 | 0.82 | ALDH1A1 (0.32) | ALDH1A1KDM4E | |
| SCHEMBL23919559 | 0.82 | SETD7 (0.31) | SETD7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| EP-3892704-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | cynora GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, OXER1, OXSR1 | ALDH1A1 2779/4885NPSR1 328/4885KDM4E 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.